Related Experiment Videos
Prolactin/cortisol ratio in rheumatoid arthritis
Angelo Zoli1, Ester Maria Ferlisi, Marco Lizzio
1Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore A. Gemelli, Rome, Italy.
Annals of the New York Academy of Sciences
|July 13, 2002
Summary
Rheumatoid arthritis (RA) patients show an altered nocturnal hormone balance, with a higher prolactin/cortisol ratio and increased inflammatory markers like IL-1beta and TNF-alpha. This hormonal imbalance contributes to the diurnal rhythm of RA disease activity.
Area of Science:
- Endocrinology
- Immunology
- Rheumatology
Background:
- Hormones like prolactin (PRL) and glucocorticoids play a role in immune system regulation.
- Rheumatoid arthritis (RA) exhibits a diurnal pattern in disease activity.
- Understanding hormonal influences on RA is crucial for managing inflammatory conditions.
Purpose of the Study:
- To investigate the diurnal variations of PRL/cortisol ratio, IL-1beta, and TNF-alpha in RA patients.
- To determine if hormonal imbalances correlate with the diurnal rhythm of RA disease activity.
- To explore the interplay between pro-inflammatory and anti-inflammatory hormones in nocturnal RA symptoms.
Main Methods:
- Blood samples were collected from RA patients and healthy controls at six time points over 24 hours (0600, 1000, 1400, 1800, 2200, 0200).
- Hormonal levels, including prolactin (PRL) and cortisol, were measured.
- Serum levels of pro-inflammatory cytokines, Interleukin-1beta (IL-1beta) and Tumor Necrosis Factor-alpha (TNF-alpha), were quantified.
Main Results:
- RA patients exhibited a significantly higher PRL/cortisol ratio at 0200 hours compared to controls.
- Serum levels of IL-1beta and TNF-alpha peaked at 0200 and 0600 hours in RA patients.
- An imbalance favoring pro-inflammatory hormones over anti-inflammatory hormones was observed during nocturnal hours in RA patients.
Conclusions:
- The study reveals a distinct nocturnal hormonal imbalance in RA patients, characterized by elevated PRL/cortisol ratios and increased pro-inflammatory cytokines.
- This hormonal dysregulation during nighttime hours is associated with the diurnal rhythm of RA disease activity.
- Findings suggest that targeting hormonal pathways may offer new therapeutic strategies for managing RA, particularly its nocturnal manifestations.